(WELL) Welltower - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US95040Q1040

Senior Housing, Wellness Communities, Real Estate

Stock: Health Care REITs
Age 25.1y

MCap 126,065m
Avg Vol 2.43M (452M USD)

Beta 0.293
Volatility 21.27%

EPS (Earnings per Share)

EPS CAGR: -36.58%
EPS Trend: 50.8%

Last SUE: -3.55
Qual. Beats: 0

Revenue

Rev. CAGR: 21.45%
Rev. Trend: 97.8%

Last SUE: -0.41
Qual. Beats: 0

Dividends

Dividend Yield	1.75%
Yield on Cost 5y	5.15%
Yield CAGR 5y	3.68%
Payout Consistency	97.5%
Payout Ratio	1.8%

Risk via 5d forecast
Volatility	21.3%
Value at Risk 5%th	35.0%
Relative Tail Risk	-0.03%

Reward TTM
Sharpe Ratio	1.53
Alpha	35.22
CAGR/Max DD	2.55

Character TTM
Hurst Exponent	0.502
Beta	0.293
Beta Downside	0.445

Drawdowns 3y
Max DD	15.05%
Mean DD	2.93%
Median DD	1.96%

Description: WELL Welltower December 02, 2025

Welltower Inc. (NYSE: WELL) is an S&P 500-listed REIT that concentrates on senior-focused rental housing and wellness communities across the United States, United Kingdom, and Canada. The company describes itself as a hybrid “operating company in a real-estate wrapper,” leveraging data-science-driven capital allocation and the proprietary Welltower Business System to generate long-term per-share growth for shareholders.

Key operational metrics (as of Q3 2024) show an occupancy rate of roughly 94% and adjusted funds from operations (AFFO) of $1.23 per share for FY 2024, reflecting a 7% year-over-year increase. The pipeline includes more than 30 new or redeveloped communities slated for completion by 2026, primarily in “micro-markets” with strong senior population growth; the U.S. 65-plus cohort is projected to rise from 56 million in 2023 to 78 million by 2035, underpinning demand. A sector-wide driver is the prevailing low-interest-rate environment, which supports REIT valuation through compressed cap rates, though any upward shift in rates could pressure pricing and financing costs.

For a deeper quantitative breakdown and scenario analysis, the ValueRay platform offers a concise, data-rich view of WELL’s valuation dynamics.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income: 958.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.81 > 1.0
NWC/Revenue: 91.01% < 20% (prev 73.19%; Δ 17.82% < -1%)
CFO/TA 0.05 > 3% & CFO 2.79b > Net Income 958.0m
Net Debt (11.36b) to EBITDA (3.50b): 3.24 < 3
Current Ratio: 5.40 > 1.5 & < 3
Outstanding Shares: last quarter (685.4m) vs 12m ago 10.85% < -2%
Gross Margin: 39.21% > 18% (prev 0.39%; Δ 3881 % > 0.5%)
Asset Turnover: 18.09% > 50% (prev 15.02%; Δ 3.07% > 0%)
Interest Coverage Ratio: 2.49 > 6 (EBITDA TTM 3.50b / Interest Expense TTM 602.6m)

Altman Z'' 0.27

A: 0.15 (Total Current Assets 10.96b - Total Current Liabilities 2.03b) / Total Assets 59.50b
B: -0.15 (Retained Earnings -8.75b / Total Assets 59.50b)
C: 0.03 (EBIT TTM 1.50b / Avg Total Assets 54.23b)
D: -0.40 (Book Value of Equity -8.28b / Total Liabilities 20.48b)
Altman-Z'' Score: 0.27 = B

Beneish M -2.91

DSRI: 0.93 (Receivables 4.15b/3.33b, Revenue 9.81b/7.35b)
GMI: 1.00 (GM 39.21% / 39.38%)
AQI: 0.94 (AQ_t 0.79 / AQ_t-1 0.85)
SGI: 1.33 (Revenue 9.81b / 7.35b)
TATA: -0.03 (NI 958.0m - CFO 2.79b) / TA 59.50b)
Beneish M-Score: -2.91 (Cap -4..+1) = A

ValueRay F-Score (Strict, 0-100) 63.24

1. Piotroski: 4.0pt
2. FCF Yield: 2.02%
3. FCF Margin: 28.26%
4. Debt/Equity: 0.47
5. Debt/Ebitda: 3.24
6. ROIC - WACC: -3.41%
7. RoE: 2.73%
8. Revenue Trend: 97.75%
9. EPS Trend: 50.83%

What is the price of WELL shares?

As of January 26, 2026, the stock is trading at USD 183.68 with a total of 3,482,719 shares traded.
Over the past week, the price has changed by -2.30%, over one month by -2.23%, over three months by +0.98% and over the past year by +35.00%.

Is WELL a buy, sell or hold?

Welltower has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy WELL.

Strong Buy: 10
Buy: 6
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WELL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	209.7	14.2%
Analysts Target Price	209.7	14.2%
ValueRay Target Price	246.5	34.2%

WELL Fundamental Data Overview January 26, 2026

P/E Trailing = 126.6759
P/E Forward = 77.5194
P/S = 12.7237
P/B = 3.2527
P/EG = 3.6218
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 137.42b USD (126.06b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
EV/FCF = 49.57x (Enterprise Value 137.42b / FCF TTM 2.77b)
FCF Yield = 2.02% (FCF TTM 2.77b / Enterprise Value 137.42b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.31 (Enterprise Value 137.42b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.22% (E(126.06b)/V(144.23b) * Re(6.99%) + D(18.16b)/V(144.23b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 6.99% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 86.98% ; FCFF base≈2.42b ; Y1≈2.88b ; Y5≈4.54b
Fair Price DCF = 158.1 (EV 119.84b - Net Debt 11.36b = Equity 108.48b / Shares 686.3m; r=6.22% [WACC]; 5y FCF grow 20.56% → 2.90% )
EPS Correlation: 50.83 | EPS CAGR: -36.58% | SUE: -3.55 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.80 | Chg30d=+0.055 | Revisions Net=-2 | Analysts=6
EPS next Year (2026-12-31): EPS=2.18 | Chg30d=-0.250 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+17.9%

Additional Sources for WELL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle